Regarding the impact of CDKN2B‐AS1 SNPs on cancer, 34 SNPs have been identified as being associated with a higher risk of developing various types of cancer, including lung, breast, gastric, thyroid, brain, endometrial, cervical, prostate, ovarian, head/neck and pancreatic cancers, among others [19]. Here, CDKN2B is linked to cancer.